Dimethyl sulfoxide activates tumor necrosis factorα-p53 mediated apoptosis and down regulates d-fructose-6-phosphate-2-kinase and lactate dehydrogenase-5 in Dalton's lymphoma in vivo

Leukemia Research

Volumn 35, Issue 7, 2011, Pages 950-956

  Koiri, Raj K ^a   Trigun, Surendra K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Apoptosis; Dalton's lymphoma; DMSO; Inducible d fructose 6 phosphate 2 kinase (iPFK2); Lactate dehydrogenase 5 (LDH 5); P53; TNF

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; CASPASE 9; DIMETHYL SULFOXIDE; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; IN VIVO STUDY; LYMPHOMA CELL; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DIMETHYL SULFOXIDE; DOWN-REGULATION; ISOENZYMES; L-LACTATE DEHYDROGENASE; LYMPHOCYTES; LYMPHOMA; MICE; MICE, INBRED AKR; PHOSPHOFRUCTOKINASE-2; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79958730142     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.12.029     Document Type: Article

References (29)

1. Santos N.C., Figueira-Coelho J., Martins-Silva J., Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003, 65:1035-1041.
2. Parisi A., Alfieri A., Mazzella M., Mazzella A., Scognamiglio M., Scognamiglio G., et al. Protective effect of dimethyl sulfoxide on acute myocardial infarction in rats. J Cardiovasc Pharmacol 2010, 55:106-109.
3. Collins S.J., Ruscetti F.W., Gallagher R.E., Gallo R.C. Terminal differentiation of human promyelocytic leukemia HL-60 cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 1978, 75:2458-2462.
4. Trubiani O., Ciancarelli M., Rapino M., Primio R.D. Dimethyl sulfoxide induces programmed cell death and reversible G1 arrest in the cell cycle of human lymphoid pre-T cell line. Immunol Lett 1996, 50:51-57.
5. Liu J., Yoshikawa H., Nakajima Y., Tasaka K. Involvement of mitochondrial permeability transition and caspase-9 activation in dimethyl sulfoxide-induced apoptosis of EL-4 lymphoma cells. Int Immunopharmacol 2001, 1:63-74.
6. Lee Y.R., Shim H.J., Yu H.N., Song E.K., Park J., Kwon K.B., et al. Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-κB activation in HL-60 cells. Leuk Res 2005, 29:401-405.
7. Choi S., Sainz B., Corcoran P., Uprichard S., Jeong H. Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells. Xenobiotica 2009, 39:205-217.
8. Ryan J.J., Clarke M.F. Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulfoxide. Leuk Res 1994, 18:617-621.
9. Sharma S., Raymond E., Soda H., Izbicka E., Davidson K., Lawrence R., et al. Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line. Leuk Res 1998, 22:663-670.
10. Kim J.W., Gardner L.B., Dang C.V. Oncogenic alterations of metabolism and the Warburg effect. Drug Discov Today 2005, 2:233-238.
11. Calvo M.N., Bartrons R., Castano E., Perales J.C., Navarro-Sabate A., Manzano A. PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett 2006, 580:3308-3314.
12. Xu R., Pelicano H., Zhou Y., Carew J.S., Feng L., Bhalla K.N., et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 2005, 65:613-621.
13. Gaber K. Energy deregulation: licensing tumors to grow. Science 2006, 312:1158-1159.
14. Koiri R.K., Trigun S.K., Mishra L., Pandey K., Dixit D., Dubey S.K. Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand. Invest New Drugs 2009, 27:503-516.
15. Sanchez-Martinez C., Aragon J.J. Analysis of phosphofructokinase subunits and isozymes in ascites tumor cells and its original tissue, murine mammary gland. FEBS Lett 1997, 409:86-90.
16. Kessler R., Bleichert F., Warnke J.P., Eschrich K. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas. J Neurooncol 2008, 86:257-264.
17. Fantin V.R., St-Pierre J., Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology and tumor maintenance. Cancer Cell 2006, 9:425-434.
18. Koiri R.K., Trigun S.K., Dubey S.K., Singh S., Mishra L. Metal Cu(II) and Zn(II) bipyridyls as inhibitors of lactate dehydrogenase. Biometals 2008, 21:117-126.
19. Vondracek J., Soucek K., Sheard M.A., Chramostova K., Andrysik Z., Hofmanova J., et al. Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukaemia U937 cell line through enhancement of mitochondrial membrane depolarization. Leuk Res 2006, 30:81-89.
20. Brown L., Ongusaha P.P., Kim H.G., Nuti S., Mandinova A., Lee J.W., et al. CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner. EMBO J 2007, 26:3410-3422.
21. Schuler M., Bossy-Wetzel E., Goldstein J.C., Fitzgerald P., Green D.R. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 2000, 275:7337-7342.
22. Soengas M.S., Alarcon R.M., Yoshida H., Giaccia A.J., Hakem R., Mak T.W., et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 1999, 284:156-159.
23. Benchimol S. p53-dependent pathways of apoptosis. Cell Death Differ 2001, 8:1049-1051.
24. Koukourakis M., Giatromanolaki A., Harris A.L., Sivridis E. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor associated stroma. Cancer Res 2006, 66:632-637.
25. Garland J.M., Halestrap A. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptosis by growth factor withdrawal by stabilizing a form of metabolic arrest. J Biol Chem 1997, 272:4680-4688.
26. Jurisic V., Bumbasirevic V., Konjevic G., Djuricic B., Spuzic I. TNF-α induced changes in LDH isozyme profile following triggering of apoptosis in PBMC of non-Hodgkin's lymphoma. Ann Hematol 2004, 83:84-91.
27. Singh S., Trigun S.K. Activation of neuronal nitric oxide synthase in cerebellum of chronic hepatic encephalopathy rats is associated with up-regulation of NADPH-producing pathway. Cerebellum 2010, 9:384-397.
28. Schreck R., Elrod L.M., Batra K.V. Cytocidal effects of dimethyl sulfoxide on normal leukemic lymphocytes. Ann NY Acad Sci 1967, 14:202-213.
29. Nasrallah F.A., Garner B., Ball G.E., Rae C. Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO). J Neurosci Res 2008, 86:208-214.